Cannabis for health use was the first legalized in Germany in 2017. Since that time, Germany’s health cannabis system has become the largest in Europe, with the government’s plan serving hundreds of thousands of suffering individuals.
Medical cannabis in Germany is set to have a significant change in the coming decades due to the recently implemented CanG law, which removes the country’s marijuana manufacturing cap ( Germany imported over 34 plenty of medical cannabis in 2023 ), and streamlines the German physician hemp supply chain.
Researchers in Germany recently examined success rates of compassionate cancer sufferers who smoked THC-containing medical cannabis items. More details about it can be found in a NORML media release below:
Berlin, Germany: The regular use of 5mg of oral THC is associated with increased life days in compassionate cancer patients, according to statistics published in the journal Medical Cannabis and Cannabinoids.
In a cohort of 9, 419 advanced cancer patients enrolled in Specialized Palliative Outpatient Care ( SAPC ), German researchers evaluated the effects of THC dosage. SAPC provides team-based home treatment for patients with innovative and progressing illnesses with life spans of days, weeks, or months.
Researchers found that people ‘ daily consumption of 4. 7mg of THC was linked to significantly longer life times, whereas lower concentrations were never.
The study’s authors concluded:” The information … demonstrate a significant effects of THC on life in mobile palliative care patients ]who] … use more than 4.7 mg/day. The median survival time increased by 15 times, from 25 days without Marijuana treatment to 40 days with a regular prescription higher than 4 7 mg per day. This extension of more than two months is deemed significant. In addition to mere survival, patients]treated ] with THC become more mentally and physically active. The people may be able to resume social contact with their friends and relatives and resolve important matters before passing away as a result of the increased exercise and improved quality of life.
The study’s findings are in line with 2021 data that equally demonstrated that THC was linked to longer survival rates in European hospice patients, especially among women over 75.
The full text of the research,” A longitudinal multinational study using tetrahydrocannabinol is associated with an increase in life day in compassionate cancer people,” appears in Medical Cannabis and Cannabinoids.
This essay first appeared on Internationalcbc.com and is syndicated these with special authority.
Photo by Dmitriy Ermakov on Unsplash
